Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound

Johanna Andersson, Johanna K Andersson, Raffaella Pozzi Mucelli, Elisabeth Epstein, E. Epstein, Elizabeth A Stewart, Kristina Gemzell-Danielsson, Kristina Gemzell‐Danielsson
European journal of obstetrics, gynecology, and reproductive biology · 2020 · vol. 254 , pp. 38–43 · doi:10.1016/j.ejogrb.2020.08.040 · PMID:32920421 · W3080821421
article OA: closed CC0 ⤵ 13 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the effects of vaginal bromocriptine treatment on adenomyosis as assessed by magnetic resonance imaging and transvaginal ultrasound.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Bromocriptine Bromocriptine Adult Female Humans Magnetic Resonance Imaging Middle Aged Pilot Projects Ultrasonography

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (14)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:21:42.008780+00:00
License: CC0 · commercial use OK